Phase 1 Pancreatitis Clinical Trials
6 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
Acute Pancreatitis
St. Jude Children's Research Hospital42 enrolled2 locationsNCT04195347
Recruiting
Phase 1
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
Chronic PancreatitisMesenchymal Stem Cells
Medical University of South Carolina42 enrolled1 locationNCT05095532
Recruiting
Phase 1
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
Chronic PainChronic Pancreatitis
VA Office of Research and Development40 enrolled1 locationNCT05925036
Recruiting
Phase 1
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
Chronic PainChronic PancreatitisChronic Pain Syndrome+1 more
Indiana University24 enrolled5 locationsNCT05603702
Recruiting
Phase 1Phase 2
Soy Tomato Juice to Improve Outcomes in Pancreatitis
Chronic PancreatitisRecurrent Acute Pancreatitis
Ohio State University35 enrolled1 locationNCT07447687
Recruiting
Phase 1Phase 2
Safety and Tolerability of Pirfenidone in Acute Pancreatitis
Pancreatitis, Acute
University of Alabama at Birmingham60 enrolled2 locationsNCT05350371